URMC Research Network - Jason Mendler

Find People

Jason Mendler

Title	Assistant Professor
Institution	School of Medicine and Dentistry
Department	Medicine
Address

Other Positions


Title	Assistant Professor
Institution	University of Rochester Medical Center
Department	Cancer Center

Awards And Honors

1997			Phi Beta Kappa \| Washington University in St. Louis
1997			Summa Cum Laude \| Washington University in St. Louis
2004			Arnold P. Gold Foundation 2004 Humanism in Medicine Essay contest-2nd prize
2004			Alpha Omega Alpha \| University Of Rochester School of Medicine
2005			: University of Rochester School of Medicine Class of 1976 Prize (In \| University of Rochester
2007			Rochester city-wide Internal Medicine resident poster day 1st place, scientific division
2007			Class of 1990 Resident Teaching Award \| voted on by the 4th year medical students at the University of R
2008			Distinction in research, Internal Medicine Residency Program \| University of Rochester
2008			Raphael Dolin Resident Research Award for dedication to patient care, critical scholarship, and teaching \| University of Rochester
2010			ASH news daily author \| ASH
2011			James V. Warren Award for accomplishments as the most outstanding research fellow in the Department of Internal Medicine \| The Ohio State University
2012			James 14th Annual Scientific Meeting award for one of top 3 Translational Research Poster \| The Ohio State University Comprehensive Cancer Center

Overview

Jason Harold Mendler, MD, PhD, Assistant Professor of Oncology, received his bachelor's degree, Summa Cum Laude, from Washington University in St. Louis, Missouri. He then went on to earn his PhD in Genetics and his medical degree at the University of Rochester School of Medicine and Dentistry in Rochester, New York. Prior to joining Wilmot Cancer Center, Dr. Mendler completed his residency at and served as chief resident of the University of Rochester Medical Center, Department of Medicine. Most recently, he completed a clinical fellowship in oncology at Ohio State University Medical Center in Columbus, Ohio and he served one year on the faculty as a clinical instructor. The recipient of numerous awards and honors, Dr. Mendler has also authored several oncology-related publications. His areas of clinical interest include acute leukemia, CML, MDS, bone marrow transplant and myclopoliferative diseases. Dr. Mendler is certified by the American Board of Internal Medicine.

Selected Publications

Mendler JH, Maharry K, Radmacher MD, Mrózek K, Becker H, Metzeler KH, Schwind S, Whitman SP, Khalife J, Kohlschmidt J, Nicolet D, Powell BL, Carter TH, Wetzler M, Moore JO, Kolitz JE, Baer MR, Carroll AJ, Larson RA, Caligiuri MA, Marcucci G, Bloomfield CD. RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures. J Clin Oncol. 2012 Sep 1; 30(25):3109-18.

View in: PubMed
Eisfeld AK, Marcucci G, Maharry K, Schwind S, Radmacher MD, Nicolet D, Becker H, Mrózek K, Whitman SP, Metzeler KH, Mendler JH, Wu YZ, Liyanarachchi S, Patel R, Baer MR, Powell BL, Carter TH, Moore JO, Kolitz JE, Wetzler M, Caligiuri MA, Larson RA, Tanner SM, de la Chapelle A, Bloomfield CD. miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia. Blood. 2012 Jul 12; 120(2):249-58.

View in: PubMed
Whitman SP, Caligiuri MA, Maharry K, Radmacher MD, Kohlschmidt J, Becker H, Mrózek K, Wu YZ, Schwind S, Metzeler KH, Mendler JH, Wen J, Baer MR, Powell BL, Carter TH, Kolitz JE, Wetzler M, Carroll AJ, Larson RA, Marcucci G, Bloomfield CD. The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia. Leukemia. 2012 Jul; 26(7):1713-7.

View in: PubMed
Mendler JH, Friedberg JW. Salvage therapy in Hodgkin's lymphoma. Oncologist. 2009 Apr; 14(4):425-32.

View in: PubMed
Mendler JH, Kelly J, Voci S, Marquis D, Rich L, Rossi RM, Bernstein SH, Jordan CT, Liesveld J, Fisher RI, Friedberg JW. Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma. Ann Oncol. 2008 Oct; 19(10):1759-64.

View in: PubMed
Mendler J. A medical experience that taught me about humanism in medicine. Acad Med. 2005 Nov; 80(11):1066.

View in: PubMed
Lissy NA, Van Dyk LF, Becker-Hapak M, Vocero-Akbani A, Mendler JH, Dowdy SF. TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point. Immunity. 1998 Jan; 8(1):57-65.

View in: PubMed